Tusamitamab Ravtansine in Patients with Advanced Solid Tumors: Phase I Study of Safety, Pharmacokinetics, and Antitumor Activity Using Alternative Dosing Regimens
Tabernero, J., Bedard, P. L., Bang, Y. J., Vieito, M., Ryu, M. H., Fagniez, N., . . . Gazzah, A. … Read More